Key to bacterial vaginosis treatment unlocked GPs say clinical changes could be on the way after a landmark study confirmed the condition is an STI, with its recurrence halved when a woman’s partner is treated simultaneously.
‘Convincing’ evidence the pill can cause depression And some types are worse than others, writes psychiatrist Professor Jayashri Kulkarni.
Endometriosis drug Visanne added to PBS Doctors have described dienogest as ‘miraculous’, with its listing expected to positively impact up to 500,000 patients.
Historic $8.5b Medicare investment explained Exactly what do the major parties’ commitments include and how will a promise to make ‘nine out of 10 visits to the GP free’ impact practices?
RACGP accepts new antidepressant deprescribing resource Tapering patients off antidepressants is a ‘poorly understood area in clinical practice’. A drug-specific, step-by-step resource, now recognised by the RACGP, aims to change that.
TGA issues weight-loss drug safety alerts Wegovy and Mounjaro are among the high-profile medicines with new product warnings, with the watchdog linking GLP-1 RAs to new side effects.
First look at early detection prostate cancer draft guidelines Currently out for consultation, the new guidelines reflect significant changes to the screening process.
What does the $573m women’s health package mean for GPs? Labor’s plan, matched by the Coalition, includes new PBS listings for contraceptive pills and MHT, new rebates, funded training, and bolstered Medicare payments for IUD insertions.
Wegovy recommended for PBS listing The PBAC recommended it be listed for adults with established cardiovascular disease with obesity.